Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Shares Outstanding (Weighted Average)
Others
Ratios

Immuneering (IMRX) Shares Outstanding (Diluted Average): 2020-2023

Historic Shares Outstanding (Diluted Average) for Immuneering (IMRX) over the last 4 years, with Dec 2023 value amounting to $28.4 million.

  • Immuneering's Shares Outstanding (Diluted Average) rose 1.97% to $29.8 million in Q3 2024 from the same period last year, while for Sep 2024 it was $29.8 million, marking a year-over-year increase of 1.97%. This contributed to the annual value of $28.4 million for FY2023, which is 7.69% up from last year.
  • Per Immuneering's latest filing, its Shares Outstanding (Diluted Average) stood at $28.4 million for FY2023, which was up 7.69% from $26.4 million recorded in FY2022.
  • Immuneering's 5-year Shares Outstanding (Diluted Average) high stood at $28.4 million for FY2023, and its period low was $5.0 million during FY2020.
  • For the 3-year period, Immuneering's Shares Outstanding (Diluted Average) averaged around $22.8 million, with its median value being $26.4 million (2022).
  • Data for Immuneering's Shares Outstanding (Diluted Average) shows a peak YoY skyrocketed of 175.00% (in 2021) over the last 5 years.
  • Immuneering's Shares Outstanding (Diluted Average) (Yearly) stood at $5.0 million in 2020, then soared by 175.00% to $13.6 million in 2021, then soared by 93.84% to $26.4 million in 2022, then climbed by 7.69% to $28.4 million in 2023.